Adzine 500 Injection
Marketer
Admac Pharma Ltd
Salt Composition
Dacarbazine (500mg)
Overview Adzine 500 Injection
Lymphoma and malignant melanoma (a skin cancer) are treated with Adzine 500 Injection. Other uses may be determined by your physician. Administered intravenously by a healthcare provider, ideally at the same time daily, dosage and frequency are determined by your doctor based on your condition and may vary. Strictly follow your doctor's instructions; incorrect usage or overdose can cause serious adverse reactions. Therapeutic benefits may not be apparent for weeks or months; do not discontinue without your doctor's approval. Common side effects—nausea, vomiting, reduced white blood cell count, and injection site pain—should be reported if persistent or worsening. Preventive measures may be available. Serious adverse effects are possible; this potent medication can impair infection resistance and affect blood, liver, or kidney function. Report unusual bleeding/bruising, fatigue, appetite loss, or jaundice to your doctor, who will monitor via regular blood tests. Inform your doctor of any pre-existing liver or kidney conditions, or medications (especially anti-infectives), before commencing treatment. Interaction with other medications is possible; disclose all medications to your doctor. This medication is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is crucial throughout treatment.
Uses of Adzine 500 Injection
Aggressive skin cancer|Lymphoma
Major Benefits of Adzine 500 Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Adzine 500 Injection:
- Nausea
- Vomiting
- Injection site pain
- Decreased white blood cell count
- Loss of appetite
How to use Adzine 500 Injection:
This medication will be administered by your physician or their designated nurse; please do not attempt self-medication.
How Adzine 500 Injection works:
Oncozine 500 Injection is a cancer therapeutic agent. Its mechanism of action involves disrupting the genetic makeup (DNA and RNA) of malignant cells, thereby halting their proliferation and expansion.
SAFETY ADVICE
AlcoholCAUTION
Adzine 500 Injection and alcohol should not be combined without medical guidance. Seek professional medical advice before concurrent use.
PregnancyCONSULT YOUR DOCTOR
Administering Adzine 500 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Adzine 500 Injection while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Adzine 500 Injection can produce adverse reactions that might impair driving ability. This impairment is a potential consequence of the injection's effects on the central nervous system.
KidneyCAUTION
Adzine 500 Injection requires careful administration for individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Adzine 500 Injection requires careful administration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Adzine 500 Injection :
Should you forget a dose of Adzine 500 Injection, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Adzine 500 Injection
| Label | Value |
|---|---|
| Type of Compound | Triazine-based compound |
| Addiction potential | None. |
| Medication Category | Cancer-fighting drugs |
| Mechanism of Action | DNA-damaging drug |
3,018 People bought this recently